HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2016 | $101 M |
2017 | $138 M |
Total: | $239 M |
Period | Weight, tons. |
---|---|
2016 | 1.08 K |
2017 | 1.23 K |
Total: | 2.32 K |
Group product | 2016 | 2017 | Ch. | ∑ (2016-2017) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | --- | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $101 M | $138 M | 38% | $239 M | 100% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $101 M | $138 M | $239 M |
№ | Country | ∑ (2016-2017) | Ratio |
---|---|---|---|
1 | Germany | $4.03 B | 20.5% |
2 | France | $1.76 B | 8.9% |
3 | Italy | $1.2 B | 6.1% |
4 | United States | $1.18 B | 6% |
5 | Switzerland | $1.04 B | 5.3% |
6 | India | $1.01 B | 5.2% |
7 | United Kingdom | $998 M | 5.1% |
8 | Hungary | $806 M | 4.1% |
9 | Netherlands | $739 M | 3.8% |
10 | Slovenia | $692 M | 3.5% |
11 | Ireland | $543 M | 2.8% |
12 | Spain | $522 M | 2.7% |
13 | Austria | $494 M | 2.5% |
14 | Belgium | $401 M | 2% |
15 | Poland | $328 M | 1.7% |
... | ... | ... | ... |
18 | Bulgaria | $259 M | 1.3% |
19 | Sweden | $256 M | 1.3% |
20 | Romania | $239 M | 1.2% |
21 | Czech Republic | $232 M | 1.2% |
22 | Denmark | $223 M | 1.1% |
... | ... | ... | ... |
The total for all countries: | $19.7 B | 100% |
№ | Region | ∑ (2016-2017) | Ratio |
---|---|---|---|
1 | Moskva | $206 M | 86.3% |
2 | Moskovskaya oblast | $32.7 M | 13.7% |
3 | Nijegorodskaya oblast | $79.3 K | 0% |
4 | Novosibirskaya oblast | $30.6 K | 0% |
By all regions: | $239 M | 100% |